RABIN KHERADPOUR: Open Payments
NPI 1093718462 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$712 in 14 payments from 5 companies in 2025. Trend: 2023 $124 · 2024 $594 · 2025 $712
Food & beverage: $712
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $210 |
| Novo Nordisk Inc | 9 | $138 |
| Phathom Pharmaceuticals, Inc. | 1 | $127 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $115 |
Products named: ZEPBOUND, VOQUEZNA, BREZTRI, JARDIANCE, Rybelsus, Ozempic.
Industry payments across TX — which companies pay providers there.
